Sansure iPonatic Nucleic Acid Detection Analyzer Obtained U.S. FDA Certification

On January 4th, the four-channel iPonatic nucleic acid detection analyzer of Sansure Biotech was certified by FDA. This is another global authority certification obtained after the approval of China NMPA and the European Union CE certification.

Sansure iPonatic Nucleic Acid Detection Analyzer break the limitation of application scenario in nucleic acid detection. It allows nucleic acid testing not only be carried out in large hospitals, but also in basic medical institutions, disease control systems, military, customs, airports and other scenarios.

At the same time, the product can improve the efficiency of nucleic acid testing and reporting in many clinical departments such as fever clinics, pediatrics, respiratory, gynecology, ICU, etc. The product can accurately detect various infectious pathogens such as COVID-19, respiratory tract, venereal disease, HPV, hand, foot and mouth, and help clinically achieve precise diagnosis and treatment.

At present, the iPonatic nucleic acid detection analyzer is widely used in clinical gene amplification testing laboratories, CDC disease prevention and control centers, scientific research institute laboratories, medical college laboratories in Germany, France, Ghana, Malaysia, Indonesia and many other countries and regions, serving the construction of public health prevention and control systems around the world.